• Home
  • News
  • Analysis
  •  
    Regions
    • South Asia
    • North America
    • Europe
    • Central Asia
    • Australasia
    • MENA
    • Southeast Asia
    • Greater China
    • North Asia
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Credit
    • Early stage
    • PIPE
  •  
    Exits
    • Buyback
    • IPO
    • Open market
    • Trade sale
  •  
    Sectors
    • Real Estate
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Industry

Investors question eligibility for HK carried interest tax concession
Investors question eligibility for HK carried interest tax concession

Fund-of-funds and family offices could be excluded from Hong Kong’s proposed carried interest tax concession, industry participants have warned.

  • Greater China
  • 22 January 2021
AVCJ Awards 2020: Fundraising of the Year - Mid Cap: Ascendent Capital Partners
AVCJ Awards 2020: Fundraising of the Year - Mid Cap: Ascendent Capital Partners

A $500 million investment in Wumart is the exception rather than the rule for Ascendent Capital Partners’ third China fund, but the digital transformation theme is a constant

  • Greater China
  • 21 January 2021
Fund focus: Novo Tellus closes second Southeast Asia fund at $250m
Fund focus: Novo Tellus closes second Southeast Asia fund at $250m

Although its second fund is considerably larger than its first, Novo Tellus Capital Partners expects to target the same kind of Southeast Asian industrial technology businesses that have succession and expansion issues

  • Southeast Asia
  • 21 January 2021
Tower Capital hits first close on Southeast Asia fund

Tower Capital, a Singapore-based GP that previously operated on a deal-by-deal basis, has achieved a first close of approximately $250 million on its first Southeast Asia-focused private equity fund.

  • Southeast Asia
  • 21 January 2021
Sinovation sharpens focus on healthcare-plus-AI

Healthcare, rather than “rocket science,” represents the biggest opportunity for artificial intelligence (AI) applications, according to Kai-Fu Lee, chairman and CEO of China’s Sinovation Ventures.

  • Greater China
  • 21 January 2021
COVID-19 changing conduct as much as tech usage
COVID-19 changing conduct as much as tech usage

Experiences vary across geographies as Asian GPs adapt to pandemic working conditions. Technology use is up, but the most lasting changes may be more cultural in nature.

  • GPs
  • 21 January 2021
Monument Group recruits Japan representative
Monument Group recruits Japan representative

Placement agent Monument Group has appointed Hiroshi Nishimuro, formerly of Morgan Stanley, as its Japan representative to lead fundraising efforts and manage GP relationships in the country.

  • North Asia
  • 20 January 2021
Pathway promotes head of Hong Kong office
Pathway promotes head of Hong Kong office

Simon Lau, who has led the Asian operations at fund-of-funds Pathway Capital Management since 2012, has been promoted to managing director.

  • LPs
  • 20 January 2021
Asia PE investment ends 2020 on a tear

A fourth-quarter surge in growth-stage deal-making took Asia private equity investment to $198.5 billion in 2020, comfortably surpassing the previous year’s total despite the strictures of COVID-19.

  • Expansion
  • 20 January 2021
Asia fund administration: Odd jobs
Asia fund administration: Odd jobs

COVID-19 is the latest in a growing list of drivers causing private equity firms to outsource various operations. The trend is implacable but inherently flexible

  • GPs
  • 20 January 2021
Lake Bleu raises $560m for Asia pre-IPO healthcare fund

Lake Bleu Capital, a Hong Kong-based private equity investor focused on healthcare, has raised $560 million for a pre-IPO fund targeting Asia with an emphasis on Greater China.

  • Greater China
  • 19 January 2021
AVCJ Awards 2020: Fundraising of the Year - Venture Capital: Ince Capital Partners
AVCJ Awards 2020: Fundraising of the Year - Venture Capital: Ince Capital Partners

A year after leaving Qiming Venture Partners, J.P. Gan raised $351.9 million for his debut fund at consumer internet-focused Ince Capital Partners

  • Greater China
  • 18 January 2021
China's Firstred targets $500m US dollar fund
China's Firstred targets $500m US dollar fund

Firstred Capital, a Chinese private equity firm established by M&A veteran Xiaodan Liu, is looking to raise approximately $500 million for its debut US dollar-denominated fund.

  • Greater China
  • 18 January 2021
SEAF hits first close on Southeast Asia women's fund
SEAF hits first close on Southeast Asia women's fund

The Southeast Asia division of US-headquartered impact private equity firm SEAF has reached a first close of at least $16 million for a women’s economic empowerment fund.

  • Southeast Asia
  • 18 January 2021
Olympus-sponsored SPAC raises $130m

Olympus Capital has raised $130 million for a special purpose acquisition company (SPAC), which it is sponsoring via its fifth pan-Asian fund.

  • Fundraising
  • 18 January 2021
AVCJ Awards 2020: Firm of the Year - Large Cap: Warburg Pincus
AVCJ Awards 2020: Firm of the Year - Large Cap: Warburg Pincus

Whether it is building a logistics platform, backing a take-private or anchoring a growth round for a tech start-up, Warburg Pincus prioritizes local partnerships in Asia

  • Greater China
  • 17 January 2021
Hong Kong regulation: Carry on

The proposal to place a 0% tax on carried interest has been welcomed in Hong Kong, but PE industry participants are quietly looking to Hong Kong Monetary Authority to ensure balanced execution of the policy

  • Greater China
  • 15 January 2021
Fund focus: Oceanpine opens to external capital
Fund focus: Oceanpine opens to external capital

Technology and healthcare-focused Oceanpine Capital sees the large GP commitment to its fund and the network of its founder as key differentiators in a competitive Chinese market

  • Greater China
  • 15 January 2021
Silver Lake raises $20b for global tech fund

Silver Lake has closed its sixth global buyout fund at the hard cap of $20 billion as the US tech investor exhibits a growing appetite for mega-deals in Asia. Its prior vintage raised $15 billion in 2017.

  • North America
  • 15 January 2021
Ascendent founder sponsors SPAC targeting global deals
Ascendent founder sponsors SPAC targeting global deals

A special purpose acquisition company (SPAC) sponsored by Liang Meng, founding managing partner of China’s Ascendent Capital Partners, has raised $300 million for global consumer technology investments.

  • Greater China
  • 15 January 2021
Singapore bourse to consider SPAC listings

The Singapore Exchange (SGX) will consider allowing listings by special purpose acquisition companies (SPACs) on the back of a spike in fundraising activity for these structures in the US.

  • Southeast Asia
  • 14 January 2021
Fund focus: Asian LPs amplify Mekong's ambitions
Fund focus: Asian LPs amplify Mekong's ambitions

Travel restrictions forced Mekong Capital to look closer to home when raising its latest fund, but the manager was already building out a more Asia-centric LP base

  • Southeast Asia
  • 13 January 2021
China's CICC raises $650m for biomedical fund
China's CICC raises $650m for biomedical fund

CICC Capital has reached a second close of RMB4.2 billion ($650 million) on its latest healthcare fund - the first in China to receive fast-track approval for its role in addressing COVID-19.

  • Greater China
  • 13 January 2021
Hong Kong's ORI hits first close on Fund II, exits Kymab

Hong Kong healthcare-focused VC firm ORI Capital has reached a first close of $112 million on its second fund and exited its largest investment, UK biotech developer Kymab, as part of a $1.1 billion deal.

  • Greater China
  • 13 January 2021
565758
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013